Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP748919.RA8GDn2UZq-3RskT0AA6VeEmqw1o5CxIddmQk__plYO00130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP748919.RA8GDn2UZq-3RskT0AA6VeEmqw1o5CxIddmQk__plYO00130_assertion type Assertion NP748919.RA8GDn2UZq-3RskT0AA6VeEmqw1o5CxIddmQk__plYO00130_head.
- NP748919.RA8GDn2UZq-3RskT0AA6VeEmqw1o5CxIddmQk__plYO00130_assertion wasGeneratedBy ECO_0000203 NP748919.RA8GDn2UZq-3RskT0AA6VeEmqw1o5CxIddmQk__plYO00130_provenance.
- NP748919.RA8GDn2UZq-3RskT0AA6VeEmqw1o5CxIddmQk__plYO00130_assertion wasDerivedFrom befree-20150227 NP748919.RA8GDn2UZq-3RskT0AA6VeEmqw1o5CxIddmQk__plYO00130_provenance.
- NP748919.RA8GDn2UZq-3RskT0AA6VeEmqw1o5CxIddmQk__plYO00130_assertion SIO_000772 23365634 NP748919.RA8GDn2UZq-3RskT0AA6VeEmqw1o5CxIddmQk__plYO00130_provenance.
- NP748919.RA8GDn2UZq-3RskT0AA6VeEmqw1o5CxIddmQk__plYO00130_assertion evidence source_evidence_literature NP748919.RA8GDn2UZq-3RskT0AA6VeEmqw1o5CxIddmQk__plYO00130_provenance.
- NP748919.RA8GDn2UZq-3RskT0AA6VeEmqw1o5CxIddmQk__plYO00130_assertion description "[Hydroxycamptothecin (HCPT) is a DNA topoisomerase I inhibitor, which has been utilized in chemotherapy for bladder cancer for nearly 40 years.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP748919.RA8GDn2UZq-3RskT0AA6VeEmqw1o5CxIddmQk__plYO00130_provenance.